Home
uniQure

uniQure Market Share Analysis for August 2026

Reimagining the future of healthcare through the power of gene therapy.

Health > Biotechnology and Pharmaceuticals

Domainuniqure.com

Year Founded1998

Employees51 - 200

Annual Revenue$500M - $1B

uniQure

uniQure (including company regionals)

uniqure.com

See more website traffic and engagement information

uniQure Revenue up to August 2026 is 500M - 1B

revenue generated by uniQure top domains

uniQure top domains revenue over 3 years

Revenue for uniQure top domains

uniqure.com500M - 1B

See more with Sales Intelligence

Total visits to uniQure's top domains

Understand uniQure market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

uniqure.com20K

See more with Sales Intelligence

Avg. visit duration in uniQure's top domains

Analyze uniQure engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

uniqure.com00:00:38

See more with Sales Intelligence

Avg. pageviews on uniQure's top domains

See how uniQure keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

uniqure.com1.77

See more with Sales Intelligence

uniQure top competitors by domain

Top similar sites in August 2026, ranked by their affinity

neuronatherapeutics.comCompany NameNeurona TherapeuticsEmployees51 - 200HQUnited States, California, South San FranciscoAnnual revenue$10M - $15MTotal visits7.8KJobs and Career > Human Resources

Top technologies used by uniQure

These are the website technologies, by industry, used by uniQure top domains

Advertising (3)

Google Adsense

Audio Video Media (2)

YouTube

Email Services (2)

Microsoft Exchange Online

Mobile (2)

Meta Viewport

More Technologies

8

See all

News & Signals from uniQure

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsUniQure NV receives financing of $259M in public offering.uniQure raises $259 million in upsized public offering to fuel gene therapy pipeline expansion.

NewsUniQure NV received financing of $225M in public offering on Jun 23rd '26.uniQure announces pricing of upsized $225 million public offering.

NewsUniQure NV is developing AMT on Jun 17th '26.A biotechnology company called UniQure has been developing a treatment called AMT-130, which uses a biological delivery system to try to reduce the harmful protein that builds up in the brains of people with Huntington's disease.